GlaxoSmithKline’s new clinical trial results suggest seniors may only need to take the pharmaceutical company’s RSV shot every other year.
GlaxoSmithKline’s new clinical trial results suggest seniors may only need to take the pharmaceutical company’s RSV shot every other year.